共 50 条
- [33] Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study LANCET REGIONAL HEALTH-EUROPE, 2024, 36
- [36] Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein JOURNAL OF CLINICAL LIPIDOLOGY, 2008, 2 (06) : 436 - 446
- [39] Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis (vol 307, pg 1302, 2012) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (18): : 1915 - 1915
- [40] Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis (vol 307, pg 1302, 2012) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (16): : 1694 - 1694